Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Shattuck Labs Inc (STTK)

Shattuck Labs Inc (STTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Shattuck Labs Inc 500 W. 5TH STREET SUITE 1200 AUSTIN TX 78701 USA

www.shattucklabs.com P: 512-900-4690

Description:

Shattuck Labs Inc. is a clinical-stage biotechnology company. It engages in development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease. The company's wholly owned program includes SL-172154. It operates principally in Durham, North Carolina and Austin, Texas. Shattuck Labs Inc. is based in Austin, United States.

Key Statistics

Overview:

Market Capitalization, $K 527,816
Enterprise Value, $K 402,186
Shares Outstanding, K 47,551
Annual Sales, $ 1,660 K
Annual Net Income, $ -87,300 K
Last Quarter Sales, $ 710 K
Last Quarter Net Income, $ -17,690 K
EBIT, $ -91,960 K
EBITDA, $ -89,400 K
60-Month Beta 1.98
% of Insider Shareholders 9.89%
% of Institutional Shareholders 58.74%
Float, K 42,848
% Float 90.11%
Short Volume Ratio 0.50

Growth:

1-Year Return 297.86%
3-Year Return -62.40%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 05/02/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -2.05
EPS Growth vs. Prev Qtr 36.92%
EPS Growth vs. Prev Year 31.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

STTK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -63.08%
Return-on-Assets % -56.05%
Profit Margin % -5,259.04%
Debt/Equity 0.00
Price/Sales 311.65
Price/Cash Flow N/A
Price/Book 3.08
Book Value/Share 3.41
Interest Coverage -3.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar